BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9821232)

  • 1. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
    Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
    Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB; Cleveland JM; Rolleri RL;
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ramipril therapy on cognitive functions in cases of mild to moderate essential hypertension.
    Qureshi N; Babbar R
    Indian J Physiol Pharmacol; 2007; 51(1):40-8. PubMed ID: 17877291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
    Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramipril vs captopril in mild to moderate hypertension.
    Yajnik VH; Vatsraj DJ; Acharya HK; Yajnik NV; Vyas NR; Vakil HB
    J Assoc Physicians India; 1994 Feb; 42(2):120-3. PubMed ID: 7860471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effectiveness of and tolerance to ramipril in the treatment of essential arterial hypertension phase 1 and 2. Results of a multicenter study].
    Fasce E; Román O; Zárate H; Prat H
    Rev Med Chil; 1997 Jan; 125(1):23-9. PubMed ID: 9336065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the evenness of the antihypertensive effect of losartan and captopril by using a 24-hour monitoring of arterial pressure].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Ter Arkh; 2001; 73(2):38-43. PubMed ID: 11338852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of single versus twice daily dosing of ramipril by ambulatory blood pressure monitoring in patients similar to those included in the HOPE study.
    Goyal D; Chong AY; Watson RL; Prasad N; Watson RD
    J Hum Hypertens; 2007 Jul; 21(7):525-30. PubMed ID: 17460714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of brerlipril in patients with non-insulin dependent diabetes mellitus and mild or moderate arterial hypertension as indicated by 24-h blood pressure monitoring].
    Ametov AS; Gubina EV; Nikolaev OG
    Ter Arkh; 1999; 71(8):17-20. PubMed ID: 10515028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Eksp Klin Farmakol; 2001; 64(2):45-50. PubMed ID: 11548448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring.
    Uchaipichat V; Koanantakul B; Suthisisang C
    J Med Assoc Thai; 2008 Sep; 91(9):1468-77. PubMed ID: 18843880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous ambulatory monitoring of the therapeutic effect of captopril, 50 mg/day, in mild and moderate essential arterial hypertension].
    Hergueta G; Estruch J
    Rev Clin Esp; 1989 Mar; 184(4):174-6. PubMed ID: 2662270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [24-hour ambulatory monitoring of blood pressure in patients with essential hypertension: the effectiveness of enalapril therapy].
    Siegelová J; Fiser B; Dusek J
    Vnitr Lek; 1996 Feb; 42(2):98-101. PubMed ID: 8686198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.